DNA methylation in glioblastoma: impact on gene expression and clinical outcome
作者： Amandine Etcheverry , Marc Aubry , Marie de Tayrac , Elodie Vauleon , Rachel Boniface
关键词:
摘要: … of methylation and gene expression profiles in 40 newly diagnosed glioblastoma patients. We also screened for associations between the level of methylation … The methylation analysis …
biomedcentral.com
springer.com
cyberleninka.org
inserm.fr
paperity.org参考文章(44)
則雄 荒木, What's going on 放射線 Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. N Engl J Med. 2005; 352: 987-96. PMID: 15758009.--神経膠腫に対する治療として、放射線治療とテモゾロマイドの併用が世界的な標準的治療となりうることを示唆する論文 Mebio oncology. ,vol. 3, pp. 132- 134 ,(2006)
Joseph F. Costello, Mitchel S. Berger, H-J. Su Huang, Webster K. Cavenee, Silencing of p16/CDKN2 Expression in Human Gliomas by Methylation and Chromatin Condensation Cancer Research. ,vol. 56, pp. 2405- 2410 ,(1996)
M. Josefa Bello, Juan A. Rey, The p53/Mdm2/p14ARF cell cycle control pathway genes may be inactivated by genetic and epigenetic mechanisms in gliomas. Cancer Genetics and Cytogenetics. ,vol. 164, pp. 172- 173 ,(2006) , 10.1016/J.CANCERGENCYTO.2005.07.002
Ilana Keshet, Yeshayahu Schlesinger, Shlomit Farkash, Eyal Rand, Merav Hecht, Eran Segal, Eli Pikarski, Richard A Young, Alain Niveleau, Howard Cedar, Itamar Simon, Evidence for an instructive mechanism of de novo methylation in cancer cells Nature Genetics. ,vol. 38, pp. 149- 153 ,(2006) , 10.1038/NG1719
Mitsutoshi Nakamura, Yasuhiro Yonekawa, Paul Kleihues, Hiroko Ohgaki, Promoter hypermethylation of the RB1 gene in glioblastomas. Laboratory Investigation. ,vol. 81, pp. 77- 82 ,(2001) , 10.1038/LABINVEST.3780213
Yeonjoo Jung, Jinah Park, Yung-Jue Bang, Tae-You Kim, Gene silencing of TSPYL5 mediated by aberrant promoter methylation in gastric cancers. Laboratory Investigation. ,vol. 88, pp. 153- 160 ,(2008) , 10.1038/LABINVEST.3700706
Ramon Martinez, Jose I. Martin-Subero, Veit Rohde, Matthias Kirsch, Miguel Alaminos, Agustín F. Fernández, Santiago Ropero, Gabriele Schackert, Manel Esteller, A microarray-based DNA methylation study of glioblastoma multiforme Epigenetics. ,vol. 4, pp. 255- 264 ,(2009) , 10.4161/EPI.9130
K. Takenaka, Carbonyl Reductase Expression and Its Clinical Significance in Non–Small-Cell Lung Cancer Cancer Epidemiology, Biomarkers & Prevention. ,vol. 14, pp. 1972- 1975 ,(2005) , 10.1158/1055-9965.EPI-05-0060
J Dunn, A Baborie, F Alam, K Joyce, M Moxham, R Sibson, D Crooks, D Husband, A Shenoy, A Brodbelt, H Wong, T Liloglou, B Haylock, C Walker, Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy. British Journal of Cancer. ,vol. 101, pp. 124- 131 ,(2009) , 10.1038/SJ.BJC.6605127
Eun Jin Kim, So Yong Lee, Tae Rim Kim, Soo Im Choi, Eun Wie Cho, Kug Chan Kim, In Gyu Kim, TSPYL5 is involved in cell growth and the resistance to radiation in A549 cells via the regulation of p21WAF1/Cip1 and PTEN/AKT pathway Biochemical and Biophysical Research Communications. ,vol. 392, pp. 448- 453 ,(2010) , 10.1016/J.BBRC.2010.01.045